Events Featured Feb 27, 2025 NMD Pharma raises awareness ahead of Rare Disease Day, 2025 Feb 27, 2025 Feb 27, 2025 Nov 30, 2024 ClC-1 inhibition for improvement of muscle function in CMT webinar Nov 30, 2024 Nov 30, 2024 Apr 25, 2024 Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma Apr 25, 2024 Apr 25, 2024 Mar 21, 2024 NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine Mar 21, 2024 Mar 21, 2024 Feb 28, 2023 Rare Disease Day, 28 February 2023 Feb 28, 2023 Feb 28, 2023 Oct 11, 2022 Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis Oct 11, 2022 Oct 11, 2022 Aug 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1 Aug 16, 2022 Aug 16, 2022 Aug 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2 Aug 16, 2022 Aug 16, 2022 Aug 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3 Aug 16, 2022 Aug 16, 2022 Aug 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A Aug 16, 2022 Aug 16, 2022 Jul 7, 2022 An active future made possible by the power of science Jul 7, 2022 Jul 7, 2022
